Status:
UNKNOWN
Dermatologic Patterns of Tuberous Sclerosis Patients and Somatic Mutation Relationship
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Tuberous Sclerosis Complex
Eligibility:
All Genders
Brief Summary
Tuberous Sclerosis is a rare genetic disorder that affects about one in 15,000 individuals. It is part of the phacomatoses: a germline mutation of the gene Tuberous Sclerosis Complex 1 (TSC1) or TSC2 ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- Diagnosis of Tuberous Sclerosis Complex established of confirmed by a geneticin, with a genetic study done or processing, patients accepting to be exanimated
- Exclusion criteria:
- \- None
Exclusion
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04112537
Start Date
March 1 2019
End Date
December 30 2020
Last Update
March 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uh Montpellier
Montpellier, France, 34295